UA72212C2 - Human bmp-7 promoter and method for exploring bone-related substance by using the same - Google Patents

Human bmp-7 promoter and method for exploring bone-related substance by using the same Download PDF

Info

Publication number
UA72212C2
UA72212C2 UA2000116830A UA2000116830A UA72212C2 UA 72212 C2 UA72212 C2 UA 72212C2 UA 2000116830 A UA2000116830 A UA 2000116830A UA 2000116830 A UA2000116830 A UA 2000116830A UA 72212 C2 UA72212 C2 UA 72212C2
Authority
UA
Ukraine
Prior art keywords
vector
bone
gene
human bmp
activity
Prior art date
Application number
UA2000116830A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of UA72212C2 publication Critical patent/UA72212C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UA2000116830A 1998-04-30 1999-04-22 Human bmp-7 promoter and method for exploring bone-related substance by using the same UA72212C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10120174A JPH11313675A (ja) 1998-04-30 1998-04-30 ヒトbmp−7プロモーターおよびこれを用いた骨関連物質の探索法
PCT/IB1999/000733 WO1999057293A1 (fr) 1998-04-30 1999-04-22 Promoteur humain bmp-7 et procédé permettant d'explorer une substance de type osseux

Publications (1)

Publication Number Publication Date
UA72212C2 true UA72212C2 (en) 2005-02-15

Family

ID=14779761

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2000116830A UA72212C2 (en) 1998-04-30 1999-04-22 Human bmp-7 promoter and method for exploring bone-related substance by using the same

Country Status (26)

Country Link
US (2) US6534268B1 (fr)
EP (1) EP1076713A1 (fr)
JP (1) JPH11313675A (fr)
KR (1) KR20010071193A (fr)
CN (1) CN1170941C (fr)
AP (1) AP1329A (fr)
AU (1) AU769124B2 (fr)
BG (1) BG64780B1 (fr)
BR (1) BR9910585A (fr)
CA (1) CA2326957A1 (fr)
EA (1) EA004509B1 (fr)
EE (1) EE200000627A (fr)
GE (1) GEP20033056B (fr)
HR (1) HRP20000736A2 (fr)
HU (1) HUP0102329A3 (fr)
ID (1) ID26704A (fr)
IL (1) IL139100A0 (fr)
NO (1) NO20005433L (fr)
NZ (1) NZ507625A (fr)
PL (1) PL343817A1 (fr)
SK (1) SK16082000A3 (fr)
TR (1) TR200003182T2 (fr)
UA (1) UA72212C2 (fr)
WO (1) WO1999057293A1 (fr)
YU (1) YU64900A (fr)
ZA (1) ZA200006080B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006516548A (ja) 2002-12-30 2006-07-06 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 迅速ゲル化ポリマー組成物からの薬物送達法
US20070015701A1 (en) * 2005-06-01 2007-01-18 Samuel Zalipsky Macromolecular conjugates of bone morphogenetic protein-7
US10500230B2 (en) * 2006-10-12 2019-12-10 DePuy Synthes Products, Inc. Kidney-derived cells and methods of use in tissue repair and regeneration
CA2681317C (fr) * 2008-05-16 2013-04-02 Industry Foundation Of Chonnam National University Peptide synthetique qui contient un peptide osteoplastique 1 (bfp1) permettant de stimuler la differenciation osteoblastique, et composition pharmaceutique comprenant ledit peptide synthetique
US9096703B2 (en) 2010-06-09 2015-08-04 Semprus Biosciences Corporation Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions
US20110305898A1 (en) 2010-06-09 2011-12-15 Zheng Zhang Non-fouling, anti-microbial, anti-thrombogenic graft compositions
CA2799639C (fr) 2010-06-09 2016-10-04 Semprus Biosciences Corp. Articles ayant des surfaces ne s'encrassant pas et leurs procedes de preparation sans modifier les proprietes physiques generales
CA2808655C (fr) 2010-08-18 2019-11-26 Emory University Composes et compositions pour ossification et procedes associes a ceux-ci
US11179500B2 (en) 2011-02-24 2021-11-23 Emory University JAB1 inhibitory compositions for ossification and methods related thereto
WO2012116135A2 (fr) 2011-02-24 2012-08-30 Emory University Compositions antagonistes de noggine pour ossification et procédés associés à celles-ci
EP2791215A4 (fr) 2011-12-14 2015-07-22 Semprus Biosciences Corp Processus d'impregnation destiné à la modification de la surface de lentilles de contact
EP2791223A4 (fr) 2011-12-14 2015-11-18 Semprus Biosciences Corp Lentilles de contact à surface modifiée
WO2013090790A1 (fr) 2011-12-14 2013-06-20 Semprus Biosciences Corp. Lentille de contact en hydrogel de silicone modifiée à l'aide d'oxydants à base de métaux lanthanides ou de transition
US9000063B2 (en) 2011-12-14 2015-04-07 Semprus Biosciences Corporation Multistep UV process to create surface modified contact lenses
US9120119B2 (en) 2011-12-14 2015-09-01 Semprus Biosciences Corporation Redox processes for contact lens modification
WO2019005563A1 (fr) * 2017-06-27 2019-01-03 St. Jude Children's Research Hospital Méthodes liées à l'activation de la voie de signalisation des protéines morphogénétiques osseuses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
EP0429570B1 (fr) 1989-03-28 1998-01-14 Genetics Institute, Inc. Compositions osteoinductrices
US5650276A (en) * 1991-03-11 1997-07-22 Creative Biomolecules, Inc. Morphogenic protein screening method
AU2407192A (en) * 1991-08-01 1993-03-02 Pharmaceutical Discovery Corporation Characterization of specific drug receptors with fluorescent ligands
AU703445B2 (en) * 1994-06-07 1999-03-25 Stryker Corporation Methods and compositions for modulating morphogenic protein expression
US6083690A (en) 1995-06-02 2000-07-04 Osteoscreen, Inc. Methods and compositions for identifying osteogenic agents
CA2272345A1 (fr) 1996-11-22 1998-06-04 Akzo Nobel Nv Promoteur de bmp-4 et utilisation d'un tel promoteur pour selectionner des agents therapeutiques destines a la prevention et/ou au traitement de l'osteoporose
US5863790A (en) 1997-05-14 1999-01-26 Minnesota Mining And Manfacturing Company Biological sterility indicator
AU745514B2 (en) * 1997-05-29 2002-03-21 Curis, Inc. Modulators of morphogen expression and methods of identifying the same

Also Published As

Publication number Publication date
TR200003182T2 (tr) 2001-02-21
BG104883A (en) 2001-05-31
NZ507625A (en) 2003-12-19
US20030040007A1 (en) 2003-02-27
CN1170941C (zh) 2004-10-13
BG64780B1 (bg) 2006-03-31
BR9910585A (pt) 2001-01-09
SK16082000A3 (sk) 2001-05-10
CA2326957A1 (fr) 1999-11-11
NO20005433D0 (no) 2000-10-27
EE200000627A (et) 2002-02-15
EA200001130A1 (ru) 2001-04-23
EP1076713A1 (fr) 2001-02-21
AU3163499A (en) 1999-11-23
CN1307643A (zh) 2001-08-08
HRP20000736A2 (en) 2001-10-31
AU769124B2 (en) 2004-01-15
AP1329A (en) 2004-11-22
ID26704A (id) 2001-02-01
EA004509B1 (ru) 2004-04-29
IL139100A0 (en) 2001-11-25
US6534268B1 (en) 2003-03-18
WO1999057293A1 (fr) 1999-11-11
HUP0102329A2 (hu) 2001-10-28
JPH11313675A (ja) 1999-11-16
HUP0102329A3 (en) 2006-03-28
ZA200006080B (en) 2001-10-29
AP2000001982A0 (en) 2000-12-31
KR20010071193A (ko) 2001-07-28
GEP20033056B (en) 2003-08-25
PL343817A1 (en) 2001-09-10
NO20005433L (no) 2000-10-27
YU64900A (sh) 2003-10-31

Similar Documents

Publication Publication Date Title
UA72212C2 (en) Human bmp-7 promoter and method for exploring bone-related substance by using the same
Winslow et al. Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation
KR100406299B1 (ko) Tgf수용체족및/또는bmp수용체족에속하는액티빈수용체유사키나제(alk)
Claesson-Welsh et al. cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules
Smith et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF
Neumaier et al. Characterization of a cDNA clone for the nonspecific cross-reacting antigen (NCA) and a comparison of NCA and carcinoembryonic antigen.
LORD et al. Type 5 acid phosphatase: Sequence, expression and chromosomal localization of a differentiation‐associated protein of the human macrophage
CN103920139A (zh) 活化素-actriia拮抗剂及在治疗或预防乳腺癌中的用途
CN109072255A (zh) 用于治疗皮肤的伤口、病症和疾病的组合物和方法
WO1999054461A2 (fr) Sequences d'acide nucleique humaines provenant d'une tumeur de l'endometre
EP1370287A2 (fr) Methode et composition permettant de moduler la croissance osseuse
Buiting et al. A putative gene family in 15q11-13 and 16p11. 2: possible implications for Prader-Willi and Angelman syndromes.
EA005496B1 (ru) Растворимый гетеродимерный рецептор цитокина
EP1181056B1 (fr) Variants d'epissage de la proteine lim de mineralisation
CN101772351A (zh) 新的骨量增加药
CA2017466A1 (fr) Facteur de calcification des os
Narducci et al. The murine Tcl1 oncogene: embryonic and lymphoid cell expression
ES2338210T3 (es) Metaloproteasa novedosa que tiene actividad agrecanasa.
CA2095729A1 (fr) Peptides solubles du recepteur du mannose
Grötzinger et al. A highly amplified mouse gene is homologous to the human interferon-responsive Sp100 gene encoding an autoantigen associated with nuclear dots
US6475735B1 (en) Human BMP-2 promoter and method for exploring bone-related substance by using the same
WO1998040487A1 (fr) Recepteur d'angiogenine, compositions et procedes associes
CN105087821A (zh) 一种诊治骨质疏松症的分子标志物
CN111139299B (zh) Josd2蛋白在制备治疗恶性肿瘤药物中的应用
IE912281A1 (en) New protein with cell-differentiation or cell-formation¹ability and recombinant process for the production